Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LUMO Lumos Pharma > Detailed Quotes

LUMO Lumos Pharma

8.850
-0.150-1.67%
Close 09/30 16:00 ET
High
9.140
Open
8.910
Turnover
58.07K
Low
8.850
Pre Close
9.000
Volume
6.43K
Market Cap
74.31M
P/E(TTM)
Loss
52wk High
10.575
Shares
8.40M
P/E(Static)
Loss
52wk Low
6.150
Float Cap
44.79M
Bid/Ask %
-42.86%
Historical High
36.720
Shs Float
5.06M
Volume Ratio
0.71
Historical Low
6.150
Dividend TTM
--
Div Yield TTM
--
P/B
1.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.13%
Amplitude
3.22%
Avg Price
9.033
Lot Size
1
Float Cap
44.79M
Bid/Ask %
-42.86%
Historical High
36.720
Shs Float
5.06M
Volume Ratio
0.71
Historical Low
6.150
Dividend TTM
--
P/B
1.00
Dividend LFY
--
Turnover Ratio
0.13%
Amplitude
3.22%
Avg Price
9.033
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.
CEO: Mr. Richard J. Hawkins
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...